Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

The closest to the recovery came the shares of AMPE, however, they had multiple Ph3 trial failures before "pulling" one last trial out which was semi-rejected by the FDA recently. What a mess.
AMPE was as high as $9 40 months ago, then it crashed to sub $2 after the CT failure. They rerun the trial, to fail again. Stock crashed to sub 0.40 at some point after raise with warrants (I don't recall the details, as it was done two or three times). Then, with the "positive" Ph3 results, the stock climbed to almost $5 (I was stupid not to sell!), and now it's about 0.50.

I have not seen too many of those stocks, as I try to stay away from those stinky companies, but you get caught in the hype from time to time. Advaxis is no different, just the level of hype is unmatched.